ArticleThe Lancet regional health. Europe2023

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry.

Sivagurunathan Sutharsan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.